Willis Sustainable Fuels Selects McDermott for SAF Facilities in the UK

McDermott has been awarded a master services agreement (MSA) by Willis Sustainable Fuels (UK) Limited (WSFL) for sustainable aviation fuel (SAF) facilities in the UK. Under the scope of the agreement, McDermott will perform early engineering, procurement and construction (EPC) related services for the facilities.

The initial phase of the agreement is the early engineering of a planned SAF facility in Teesside with capacity of producing 50,000 litres per day of SAF. The project is supported by the UK Government's Advanced Fuels Fund. The intent is for the parties to enter a sole-source negotiation of the EPC scope in 2025. WSFL intends to deploy technology which produces next-generation SAF, either Biogas-to-Liquid (BtL) or Power-to-Liquid (PtL), depending on the feedstock.

"Our partnership with McDermott on one of the UK's most advanced sustainable aviation fuel projects represents a key milestone in our ongoing efforts to lead the way in aviation decarbonization. This collaboration underscores our commitment to working with industry leaders who share our vision for a cleaner, more sustainable future," said Amy Ruddock, Senior Vice President, Sustainable Aviation & Corporate Development at Willis Lease Finance Corporation, WSFL's parent company.

McDermott will be supported by its construction partner, Bilfinger UK. Together, they will maximise in-house know how, self-perform delivery and the UK supply chain.

"This agreement is testament to McDermott's expertise in integrating design, fabrication and installation, and our capabilities across low carbon solutions," said Rob Shaul, McDermott's Senior Vice President, Low Carbon Solutions business. "We are well positioned to offer WSFL a self-perform EPC model via our strategic relationship with Bilfinger UK, which is expected to further reduce risk and drive cost optimizations."

The work will be led from McDermott's office in London, with support from its Gurugram, India office, and Bilfinger's office in Warrington, UK.